FDA inspection
Aurobindo Pharma Ltd: FDA inspection ending Oct 22, 2009
FDA inspection 636499 · No Action Indicated (NAI) · Medchal
Key facts
| Inspection ID | 636499 |
|---|---|
| Firm | Aurobindo Pharma Ltd |
| FEI number | 3004021229 |
| Address | Unit 3, Survey 313 & 314, Bachupally, Medchal-Malkajgiri District |
| City | Medchal |
| Country | India |
| Fiscal year | 2010 |
| Inspection end date | Oct 22, 2009 |
| Classification | No Action Indicated (NAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data